Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2013 Oct 24;17(5):R255.
doi: 10.1186/cc13082.

Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock

Observational Study

Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock

Boris Jung et al. Crit Care. .

Abstract

Introduction: Procalcitonin (PCT) biomarker is suggested to tailor antibiotic therapy in the medical intensive care unit (ICU) but studies in perioperative medicine are scarce. The aim of this study was to determine whether PCT reported thresholds are associated with the initial treatment response in perioperative septic shock secondary to intra-abdominal infection.

Methods: This single ICU, observational study included patients with perioperative septic shocks secondary to intra-abdominal infection. Demographics, PCT at days 0, 1, 3, 5, treatment response and outcome were collected. Treatment failure included death related to the initial infection, second source control treatment or a new onset intra-abdominal infection. The primary endpoint was to assess whether PCT thresholds (0.5 ng/ml or a drop from the peak of at least 80%) predict the initial treatment response.

Results: We included 101 consecutive cases. Initial treatment failed in 36 patients with a subsequent mortality of 75%. Upon admission, PCT was doubled when treatment ultimately failed (21.7 ng/ml ± 38.7 vs. 41.7 ng/ml ± 75.7; P = 0.04). Although 95% of the patients in whom PCT dropped down below 0.5 ng/ml responded to treatment, 50% of the patients in whom PCT remained above 0.5 ng/ml also responded successfully to treatment. Moreover, despite a PCT drop of at least 80%, 40% of patients had treatment failure.

Conclusions: In perioperative intra-abdominal infections with shock, PCT decrease to 0.5 ng/ml lacked sensitivity to predict treatment response and its decrease of at least 80% from its peak failed to accurately predict treatment response. Studies in perioperative severe infections are needed before using PCT to tailor antibiotic use in this population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
Treatment response according to procalcitonin drop. (A) Percentage of treatment success according to the lowest PCT value from ICU admission to day 5. Patients were dichotomized according to whether the lowest PCT value was inferior to 0.5 ng/ml or not. Among the 31 patients in whom PCT decreased below the threshold of 0.5 ng/ml, 29 responded successfully to the treatment. Thirty-one patients among 64 did also respond successfully to treatment although PCT remained superior to 0.5 ng/ml. (B) Percentage of treatment success according to PCT decrease from its peak value from ICU admission to day 5. Patients were dichotomized according to whether the PCT value decreased by more than 80% of the peak value or not. Among the 58 patients in whom PCT decreased by at least 80% from its peak, 38 responded successfully to the treatment. Twenty-two patients among 37 did also respond successfully to treatment although PCT drop was lower than 80% of the peak. (C) Percentage of treatment success according the lowest PCT value and the PCT decrease from its peak value from ICU admission to day 5 (combination of (A) and (B)). Among the 20 patients in whom PCT both decreased by at least of 80% from its peak and below 0.5 ng/ml, 19 responded successfully to the treatment. Twelve patients among 26 did also respond successfully to treatment although PCT drop was lower than 80% of its peak and its absolute value remained superior to 0.5 ng/ml. On the x-axis is presented the number of patients in whom the treatment was successful of the number of patients analyzed. Six patients could not be analyzed because of logistical reasons.
Figure 3
Figure 3
Treatment response according to temperature, C-reactive protein, serum procalcitonin and SOFA score kinetics. Kinetics of temperature (A), C-reactive protein (B), serum procalcitonin (C) and Sepsis-related Organ Failure Assessment (SOFA) score (D) in patients according to the initial treatment response from day 0 to day 5. Comparisons were made to assess whether the biomarkers kinetic and not their absolute values are different according to the initial treatment impact between day 0 and day 5. Results are expressed as means ± standard error for the mean (SEM). On the x-axis is presented the number of patients in whom data were available.

Comment in

Similar articles

Cited by

  • A Focus on Intra-Abdominal Sepsis with Biomarkers: A Literature Review.
    Peksöz R, Ağırman E, Şentürk F, Albayrak Y, Atamanalp SS. Peksöz R, et al. Eurasian J Med. 2022 Dec;54(Suppl1):66-70. doi: 10.5152/eurasianjmed.2022.22296. Eurasian J Med. 2022. PMID: 36655448 Free PMC article.
  • Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference.
    Sartelli M, Catena F, Abu-Zidan FM, Ansaloni L, Biffl WL, Boermeester MA, Ceresoli M, Chiara O, Coccolini F, De Waele JJ, Di Saverio S, Eckmann C, Fraga GP, Giannella M, Girardis M, Griffiths EA, Kashuk J, Kirkpatrick AW, Khokha V, Kluger Y, Labricciosa FM, Leppaniemi A, Maier RV, May AK, Malangoni M, Martin-Loeches I, Mazuski J, Montravers P, Peitzman A, Pereira BM, Reis T, Sakakushev B, Sganga G, Soreide K, Sugrue M, Ulrych J, Vincent JL, Viale P, Moore EE. Sartelli M, et al. World J Emerg Surg. 2017 May 4;12:22. doi: 10.1186/s13017-017-0132-7. eCollection 2017. World J Emerg Surg. 2017. PMID: 28484510 Free PMC article. Review.
  • Importance of Source Control in the Subgroup of Intra-Abdominal Infections for Septic Shock Patients: Analysis of 390 Cases.
    Önal U, Akyol Seyhan D, Ketenoğlu OB, Mert Vahabi M, Başkol Elik D, Memetali SC, Şanlıdağ İşbilen G, Bulut Avşar C, Kaya A, Uyan-Önal A, Yalçın N, Guliyeva G, Dirik Ş, Acet O, Akdağ D, Görür MD, Bozbıyık O, Göktepe B, Gümüş T, Çankayalı İ, Demirağ K, Uyar M, Sipahi H, Erdem HA, Işıkgöz Taşbakan M, Arda B, Aydemir Ş, Ulusoy S, Sipahi OR. Önal U, et al. Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024051. doi: 10.4084/MJHID.2024.051. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38984090 Free PMC article.
  • Procalcitonin: Where Are We Now?
    Hamade B, Huang DT. Hamade B, et al. Crit Care Clin. 2020 Jan;36(1):23-40. doi: 10.1016/j.ccc.2019.08.003. Epub 2019 Oct 21. Crit Care Clin. 2020. PMID: 31733680 Free PMC article. Review.
  • Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.
    Montravers P, Tubach F, Lescot T, Veber B, Esposito-Farèse M, Seguin P, Paugam C, Lepape A, Meistelman C, Cousson J, Tesniere A, Plantefeve G, Blasco G, Asehnoune K, Jaber S, Lasocki S, Dupont H; DURAPOP Trial Group. Montravers P, et al. Intensive Care Med. 2018 Mar;44(3):300-310. doi: 10.1007/s00134-018-5088-x. Epub 2018 Feb 26. Intensive Care Med. 2018. PMID: 29484469 Clinical Trial.

References

    1. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;17:234–240. doi: 10.1001/jama.1996.03530270074035. - DOI - PubMed
    1. Chastre J, Wolff M, Fagon J-Y, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;17:2588–2598. doi: 10.1001/jama.290.19.2588. - DOI - PubMed
    1. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;17:1791–1799. doi: 10.1378/chest.125.5.1791. - DOI - PubMed
    1. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;17:505–511. doi: 10.1164/ajrccm.162.2.9909095. - DOI - PubMed
    1. Nobre V, Harbarth S, Graf J-D, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2007;17:498–505. - PubMed

Publication types

LinkOut - more resources